Search results
Results from the WOW.Com Content Network
N-Benzyl-2C-B (25B-NB, NB-2C-B) is a recreational designer drug from the 25-NB subgroup of the substituted phenethylamine family, with psychedelic effects. It has a binding affinity (K i ) of 16 nM at the serotonin receptor 5-HT 2A and 90 nM at 5-HT 2C and reportedly has a potency in between that of 2C-B and NBOMe-2C-B .
The 25-NB (25x-NBx) series, or NBOMe series, also known as the N-benzylphenethylamines, is a family of serotonergic psychedelics. [ 1 ] [ 2 ] They are substituted phenethylamines and were derived from the 2C family . [ 2 ]
The N-benzyl derivative however was found to have higher binding affinity than 2C-B itself, with N-(4-bromobenzyl)-2CB binding even more tightly. [49] This initial research did not include functional assays of activity, but later led to the development of potent substituted N-benzyl derivatives such as 25B-NBOMe, [50] and 25B-NBOH.
Like other 2C-X-NBOMe molecules, 25I-NBOMe is a derivative of the 2C family of phenethylamines described by chemist Alexander Shulgin in his book PiHKAL. [ 17 ] [ 15 ] Specifically, 25I-NBOMe is an N -benzyl derivative of the phenethylamine molecule 2C-I , formed by adding a 2-methoxybenzyl (BnOMe) onto the nitrogen (N) of the phenethylamine ...
The United States Drug Enforcement Administration (DEA) maintains lists regarding the classification of illicit drugs (see DEA Schedules).It also maintains List I of chemicals and List II of chemicals, which contain chemicals that are used to manufacture the controlled substances/illicit drugs.
While the N-benzyl derivatives of 2C-I had significantly increased binding to 5HT 2A receptor fragments, compared to 2C-I, the N-benzyl derivatives of DOI were less active compared to DOI. [ 4 ] 25I-NBOH is notable as one of the most selective agonist ligands for the 5-HT 2A receptor with an EC 50 value of 0.074 nM with more than 400 times ...
N-Ethyl-2C-B is a recreational designer drug with psychedelic effects. [1] It was first synthesised in the 1990s, [2] and was first identified as a new psychoactive substance in Finland in 2007. [3] It is specifically listed as an illegal drug in Finland, [4] and controlled under analogue provisions in a number of other jurisdictions.
2C-B-BZP contains a benzylpiperazine base as well as the ring-substitution pattern of the psychedelic phenethylamine 2C-B. 2C-B-BZP is not a phenethylamine itself and does not produce psychedelic effects, as the binding groups are in the wrong position to activate the 5-HT 2A receptor, while the phenylpiperazine homologue 2C-B-PP substitutes for DOM in DOM-trained rats with around one-tenth ...